Annual Retained Earnings
-$512.16 M
-$74.96 M-17.15%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual retained earnings is -$512.16 million, with the most recent change of -$74.96 million (-17.15%) on December 31, 2023.
- During the last 3 years, EIGR annual retained earnings has fallen by -$205.66 million (-67.10%).
- EIGR annual retained earnings is now -570.73% below its all-time high of -$76.36 million, reached on December 31, 2016.
Performance
EIGR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$512.16 M
-$13.45 M-2.70%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly retained earnings is -$512.16 million, with the most recent change of -$13.45 million (-2.70%) on December 31, 2023.
- Over the past year, EIGR quarterly retained earnings has dropped by -$74.96 million (-17.15%).
- EIGR quarterly retained earnings is now -1212.58% below its all-time high of -$39.02 million, reached on March 31, 2016.
Performance
EIGR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
EIGR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -17.1% |
| 3 y3 years | -67.1% | -67.1% |
| 5 y5 years | -199.2% | -199.2% |
EIGR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.5% | at low | -50.5% | at low |
| 5 y | 5-year | -112.1% | at low | -112.1% | at low |
| alltime | all time | -570.7% | at low | -1212.6% | at low |
Eiger BioPharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$512.16 M(+17.1%) | -$512.16 M(+2.7%) |
| Sep 2023 | - | -$498.70 M(+3.8%) |
| Jun 2023 | - | -$480.67 M(+4.5%) |
| Mar 2023 | - | -$459.98 M(+5.2%) |
| Dec 2022 | -$437.19 M(+28.4%) | -$437.19 M(+6.1%) |
| Sep 2022 | - | -$412.06 M(+7.0%) |
| Jun 2022 | - | -$384.94 M(+6.0%) |
| Mar 2022 | - | -$363.06 M(+6.7%) |
| Dec 2021 | -$340.42 M(+11.1%) | -$340.42 M(+6.8%) |
| Sep 2021 | - | -$318.65 M(+7.5%) |
| Jun 2021 | - | -$296.43 M(+6.9%) |
| Mar 2021 | - | -$277.25 M(-9.5%) |
| Dec 2020 | -$306.50 M(+26.9%) | -$306.50 M(+6.5%) |
| Sep 2020 | - | -$287.69 M(+5.8%) |
| Jun 2020 | - | -$272.01 M(+6.0%) |
| Mar 2020 | - | -$256.69 M(+6.3%) |
| Dec 2019 | -$241.45 M(+41.0%) | -$241.45 M(+7.5%) |
| Sep 2019 | - | -$224.53 M(+9.0%) |
| Jun 2019 | - | -$205.91 M(+9.3%) |
| Mar 2019 | - | -$188.39 M(+10.0%) |
| Dec 2018 | -$171.20 M | -$171.20 M(+10.7%) |
| Sep 2018 | - | -$154.70 M(+12.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$137.55 M(+7.8%) |
| Mar 2018 | - | -$127.64 M(+7.4%) |
| Dec 2017 | -$118.81 M(+55.6%) | -$118.81 M(+10.1%) |
| Sep 2017 | - | -$107.91 M(+9.3%) |
| Jun 2017 | - | -$98.74 M(+12.7%) |
| Mar 2017 | - | -$87.60 M(+14.7%) |
| Dec 2016 | -$76.36 M(-60.0%) | -$76.36 M(+20.1%) |
| Sep 2016 | - | -$63.59 M(+21.8%) |
| Jun 2016 | - | -$52.22 M(+33.8%) |
| Mar 2016 | - | -$39.02 M(-79.6%) |
| Dec 2015 | -$190.85 M(+30.3%) | -$190.85 M(+2.6%) |
| Sep 2015 | - | -$186.11 M(+3.6%) |
| Jun 2015 | - | -$179.71 M(+10.1%) |
| Mar 2015 | - | -$163.19 M(+11.4%) |
| Dec 2014 | -$146.44 M(+30.1%) | -$146.44 M(+8.4%) |
| Sep 2014 | - | -$135.10 M(+6.6%) |
| Jun 2014 | - | -$126.74 M(+5.8%) |
| Mar 2014 | - | -$119.75 M(+6.4%) |
| Dec 2013 | -$112.59 M(+21.6%) | -$112.59 M(+5.8%) |
| Sep 2013 | - | -$106.41 M(+5.4%) |
| Jun 2013 | - | -$100.95 M |
| Dec 2012 | -$92.59 M(+20.4%) | - |
| Dec 2011 | -$76.87 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual retained earnings year-on-year change?
- What is Eiger BioPharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly retained earnings year-on-year change?
What is Eiger BioPharmaceuticals annual retained earnings?
The current annual retained earnings of EIGR is -$512.16 M
What is the all time high annual retained earnings for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual retained earnings is -$76.36 M
What is Eiger BioPharmaceuticals annual retained earnings year-on-year change?
Over the past year, EIGR annual retained earnings has changed by -$74.96 M (-17.15%)
What is Eiger BioPharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of EIGR is -$512.16 M
What is the all time high quarterly retained earnings for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly retained earnings is -$39.02 M
What is Eiger BioPharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, EIGR quarterly retained earnings has changed by -$74.96 M (-17.15%)